Medtronic makes history in neurostimulation devices today, receiving FDA-approval for the first implantable spinal cord stimulation systems for use in the treatment of back pain for conditionally safe full-body MRI under specific conditions. Its RestoreSensor® SureScan® MRI neurostimulation systems will allow patients with the implant to undergo an MRI, previously impossible due to the magnetic fields and radio frequency that would impact such a device in a patient.
According to the company website:
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The systems also include a proprietary SureScan feature, which sets the neurostimulator into an appropriate mode for the MRI environment, enabling the radiology departments to easily and conveniently confirm a patient’s implantable system is safe for MRI scanning.
“In today’s medical practice, MRI examinations are necessary and routinely performed for diagnosis and clinical care,” Dr. Ali Rezai, one of the first doctors to implant the device, said. “It is very likely that a patient with chronic pain, spinal disease, neurological and orthopedic disorders will require an MRI scan.”
For more, read the company’s press release.
